Combined effects of angiotensin converting enzyme inhibition and angiotensin II receptor antagonism in conscious pigs with congestive heart failure.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Cardiovascular Research

• Publication date

  1998-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0008-6363(98)00117-5PMID 9798526
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Lack of beneficial effects of growth hormone treatment in conscious dogs during development of heart failure.

  1998cited by this paper
• Central gain of the cardiac sympathetic afferent reflex in dogs with heart failure.

  1997cited by this paper
• Enalaprilat augments arterial and cardiopulmonary baroreflex control of sympathetic nerve activity in patients with heart failure.

  1996cited by this paper
• Effects of angiotensin II generated by an angiotensin converting enzyme-independent pathway on left ventricular performance in the conscious baboon.

  1995cited by this paper
• Contribution of kinins to the cardiovascular actions of angiotensin-converting enzyme inhibitors.

  1995cited by this paper
• Factors involved in delaying the rise in peripheral resistance in developing heart failure.

  1994cited by this paper
• The Cardiomyopathy of Overload: An Unnatural Growth Response in the Hypertrophied Heart

  1994cited by this paper
• Endothelium-dependent relaxation by angiotensin-converting enzyme inhibitors in canine femoral arteries.

  1994cited by this paper
• Angiotensin-converting enzyme inhibitors unmask endogenous kinin production by bovine coronary artery endothelium.

  1993cited by this paper
• Converting enzyme inhibition modulates sympathetic neurotransmission in vivo via multiple mechanisms.

  1993cited by this paper
• Endothelium-dependent effects of converting-enzyme inhibitors.

  1993cited by this paper
• Hormonal response of the premature primate to operative stress.

  1993cited by this paper
• ENALAPRILAT RESTORES SENSITIVITY OF BAROREFLEX CONTROL OF RENAL AND TOTAL NORADRENALINE SPILLOVER IN HEART FAILURE RABBIT

  1993cited by this paper
• In vivo pharmacology of L-158,809, a new highly potent and selective nonpeptide angiotensin II receptor antagonist.

  1992cited by this paper
• Local production of kinins contributes to the endothelium dependent relaxations evoked by converting enzyme inhibitors in isolated arteries.

  1992cited by this paper
• In vitro pharmacology of L-158,809, a new highly potent and selective angiotensin II receptor antagonist.

  1992cited by this paper
• Mechanism of Coronary Vasodilation Produced by Bradykinin

  1991cited by this paper
• Systemic vasoconstriction induced by inhibition of nitric oxide synthesis is attenuated in conscious dogs with heart failure.

  1991cited by this paper
• Identification of a highly specific chymase as the major angiotensin II-forming enzyme in the human heart.

  1990cited by this paper
• Kinin-related effects of angiotensin-converting enzyme inhibition.

  1990cited by this paper
• Angiotensin II-forming pathways in normal and failing human hearts.

  1990cited by this paper
• Heart failure depresses endothelium-dependent responses in canine femoral artery.

  1989cited by this paper
• Different distribution of two types of angiotensin II-generating enzymes in the aortic wall.

  1987cited by this paper
• Effect of Vasodilator Therapy on Mortality in Chronic Congestive Heart Failure. Results of a Veterans Administration Cooperative Study

  1987cited by this paper
• Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study.

  1986cited by this paper
• Effect of Vasodilator Therapy on Mortality in Chronic Congestive Heart Failure

  1986cited by this paper
• The relationship of plasma catecholamines to acute metabolic and hormonal responses to injury in man.

  1985cited by this paper
• Evidence for a putatively new angiotensin II-generating enzyme in the vascular wall.

  1984cited by this paper
• Activity of the sympathetic nervous system and renin-angiotensin system assessed by plasma hormone levels and their relation to hemodynamic abnormalities in congestive heart failure.

  1982cited by this paper
• Mechanism of plasma catecholamine increases during surgical stress in man.

  1977cited by this paper
• Effects of Halothane on Left Ventricular Function and Distribution of Regional Blood Flow in Dogs and Primates

  1974cited by this paper
• Cardiovascular Research

  1966cited by this paper

• Will Pig Organ Xenotransplantation in Patients Complicate the Use of Commonly Administered Drugs?

  2025cites this paper
• The dilemma of dual renin-angiotensin system blockade in chronic kidney disease: why beneficial in animal experiments but not in the clinic?

  2017cites this paper
• Chapter 6 – Animal Models for Cardiovascular Research

  2017cites this paper
• Animal Models for Cardiovascular Research

  2013cites this paper
• Effects of different AT1-receptor antagonists in the therapy of severe heart failure pretreated with ACE inhibitors

  2007cites this paper
• Combined effects of ramipril and angiotensin II receptor blocker TCV116 on rat congestive heart failure after myocardial infarction.

  2005cites this paper
• Combined Blockade of the Renin Angiotensin System with ACE Inhibitors and AT1 Receptor Antagonists

  2004cites this paper
• Effects of AT1 receptor antagonist therapy in patients with severe heart failure pretreated with angiotensin-converting enzyme inhibitors CLINICAL CARDIOLOGY

  2003cites this paper
• Effects of AT1 receptor antagonist therapy in patients with severe heart failure pretreated with angiotensin-converting enzyme inhibitors.

  2002cites this paper
• Effectively targetting the renin-angiotensin-aldosterone system in cardiovascular and renal disease: rationale for using angiotensin II receptor blockers in combination with angiotensin-converting enzyme inhibitors

  2000cites this paper
• Effects of ACE inhibitor, AT1 antagonist, and combined treatment in mice with heart failure.

  2000cites this paper
• Combination Therapy with Angiotensin Converting Enzyme Inhibition and AT1 Receptor Inhibitor on Ventricular Remodeling After Myocardial Infarction in Rats

  2000cites this paper
• Renin-angiotensin system inhibition on noradrenergic nerve terminal function in pacing-induced heart failure.

  2000cites this paper